Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
19
Number of overlapping holdings
30.6%
% of XLV's 62 holdings also in FMED
32.8%
% of FMED's 65 holdings also in XLV
Overlap by Weight
Sector Drift (XLV minus FMED)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in FMED |
Overlap | |
|---|---|---|---|---|
 |
UNITEDHEALTH GROUP INC | 9.3% | 4.7% | 4.7% |
|
INTUITIVE SURGICAL INC | 3.7% | 3.8% | 3.7% |
|
DANAHER CORP | 2.9% | 3.9% | 2.9% |
|
BOSTON SCIENTIFIC CORP | 2.6% | 5.6% | 2.6% |
|
STRYKER CORP | 2.5% | 2.5% | 2.5% |
Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to FMED
|
ELI LILLY & CO | 9.7% |
|
JOHNSON & JOHNSON | 6.8% |
|
ABBVIE INC | 5.9% |
|
UNITEDHEALTH GROUP INC | 4.6% |
|
ABBOTT LABORATORIES | 3.8% |
|
AMGEN INC | 2.8% |
|
PFIZER INC | 2.8% |
|
MERCK & CO. INC. | 2.7% |
|
GILEAD SCIENCES INC | 2.2% |
|
BRISTOL-MYERS SQUIBB CO | 2.2% |
XLV Underweight Relative to FMED
|
ALNYLAM PHARMACEUTICALS INC | -4.4% |
|
BOSTON SCIENTIFIC CORP | -3.0% |
|
INSULET CORP | -3.0% |
|
LEGEND BIOTECH CORPORATION SPONSORED | -3.0% |
 |
ARGENX SE ADR | -2.9% |
|
EXACT SCIENCES CORP | -2.6% |
|
UCB SA | -2.3% |
|
REGENERON PHARMACEUTICALS | -2.3% |
|
PENUMBRA, INC. | -2.1% |
|
ROYALTY PHARMA PLC CLASS A | -2.1% |